Cargando…
Indoxyl sulfate impairs valsartan-induced neovascularization()
Studies revealed that the use of renin-angiotensin-aldosterone system antagonism is not associated with a statistically significant reduction in the risk of cardiovascular events in patients with chronic kidney disease (CKD) compared with that in the general population. We tested the hypothesis that...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974788/ https://www.ncbi.nlm.nih.gov/pubmed/31972507 http://dx.doi.org/10.1016/j.redox.2020.101433 |